Redshift Bioanalytics Inc.
Boxborough, MA
- UEI
- UJ1TNDNGLFW7
- CAGE
- 9CEB8
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 80 Central St, Boxborough, MA 01719, USA
- Website
- redshiftbio.com
- Founded
- 2005
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $26,250 |
| FY2024 | $139,900 |
Contract awards
Similar vendors
About the company
Redshift Bioanalytics Inc. is a for-profit corporate entity registered in SAM.gov, specializing in the manufacture and sale of advanced bioanalytical instruments and related services. The company appears to be a sophisticated technology provider focused on precision scientific equipment for research and medical applications, with a primary operational base in Hamilton, Montana. Their business model centers on developing and maintaining high-end scientific instrumentation, particularly in the fields of protein structure analysis, data acquisition systems, and biomedical research technologies.
The company has exclusively secured federal contract awards from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), between 2022 and 2024. These awards consistently involve the procurement and maintenance of specialized scientific instruments, including the AQS3/APOLLO systems, Aurora MMS system, and Microfluidic Modulation Spectroscopy units. The contract awards range from $26,250 to $245,000, and are structured as firm-fixed-price purchase orders. Each contract has been awarded on a non-set-aside basis, indicating Redshift Bioanalytics competes openly for federal contracts. The contracts primarily support vaccine development, bacterial metabolism research, and high-throughput protein structure analysis, with services encompassing system procurement, software installation, maintenance, technical support, and on-site and remote repair services. All contracts have been with civilian agencies and do not involve defense-specific work.
Quick answers
Is Redshift Bioanalytics Inc. registered in SAM.gov?
Yes. Redshift Bioanalytics Inc.'s SAM.gov registration is active through April 6, 2027.
How much has Redshift Bioanalytics Inc. received in federal contracts?
Federal contracts obligated $26,250 to Redshift Bioanalytics Inc. in fiscal year 2025 and $166,150 in fiscal years 2023 through 2027.
What is Redshift Bioanalytics Inc.'s most recent federal award?
Redshift Bioanalytics Inc.'s most recent federal contract award is Annual service contract for AQS3/apollo (75N93025P00126), from National Institute of Allergy and Infectious Diseases (NIH), on December 6, 2024.
On GovTribe
See Redshift Bioanalytics Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors